Suppose your doctor could tell whether your Stage I breast cancer was likely to metastasize? What if your oncologist could monitor the response of your cancer to chemotherapy? A new study about circulating tumor cells is bringing that day closer. Doctors have known for decades that cancer cells can break off from a primary tumor and travel to a different part of the body. They understood that the bloodstream is the... read more..
Friday, 15 June 2012
Stage I Breast Cancer-Primary Tumor-Cancer Cells
Monday, 21 May 2012
American Cancer Society-Breast Cancer Incidence-Hormonal Therapy
A vaccine that targets cancer cells in combination with the drug letrozole, a standard hormonal therapy against breast cancer, significantly increased survival when tested in mice, a team of UC Davis investigators has found. The findings were published in the journal Clinical Cancer Research... read more..
Long-term incidence of breast cancer by trial arm in one county of the Swedish Two-County Trial of mammographic screening
CONCLUSIONS:There was no additional breast cancer incidence associated with 100,000 additional screens in the ASP. Results suggest that overdiagnosis is small and largely confined to the prevalence screen. Cancer 2012. © 2012 American Cancer Society. (Source: Cancer) read more..
Thursday, 5 April 2012
Signaling Pathway-Breast Cancer-Cancer Cells-Immune Cells
Lymph nodes help to fight off infections by producing immune cells and filtering foreign materials from the body, such as bacteria or cancer cells. Thus, one of the first places that cancer cells are found when they leave the primary tumor is in the lymph nodes... read more..
Tuesday, 20 March 2012
Ucla's Jonsson Comprehensive Cancer Center-Early Stage Breast Cancer-Radiation Treatments
In a groundbreaking new study just published in the peer reviewed journal Stem Cells, researchers at UCLA's Jonsson Comprehensive Cancer Center Department of Oncology found that, despite killing half of all tumor cells per treatment, radiation treatments on breast cancer... (Source: NaturalNews.com) read more..
iCAD launches study of intra-operative RT for breast cancer
A post-market study has been launched to assess the safety and efficacy of iCAD’s FDA-cleared Xoft Axxent eVx System when used for single-fraction, intra-operative radiation therapy at the time of lumpectomy for early stage breast cancer. (Source: Health Imaging News) read more..
CTC Count: Liquid Biopsy?CTC Count: Liquid Biopsy?
Kerr reports on the largest prospective study showing the significant prognostic value of circulating tumor cells in breast cancer, and suggests manipulation of CTCs as a liquid biopsy is not far off. Medscape Hematology-Oncology (Source: Medscape Today Headlines) read more..